CN108576823A - A kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application - Google Patents
A kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application Download PDFInfo
- Publication number
- CN108576823A CN108576823A CN201810104943.7A CN201810104943A CN108576823A CN 108576823 A CN108576823 A CN 108576823A CN 201810104943 A CN201810104943 A CN 201810104943A CN 108576823 A CN108576823 A CN 108576823A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- aging
- oxidant
- unit composition
- symphysis unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 83
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 78
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 78
- 235000006708 antioxidants Nutrition 0.000 title claims abstract description 78
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000006041 probiotic Substances 0.000 claims abstract description 65
- 235000018291 probiotics Nutrition 0.000 claims abstract description 65
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 61
- 241000894006 Bacteria Species 0.000 claims abstract description 16
- 239000004615 ingredient Substances 0.000 claims description 33
- 244000063299 Bacillus subtilis Species 0.000 claims description 20
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 20
- 241000194032 Enterococcus faecalis Species 0.000 claims description 20
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 20
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 20
- 241000186679 Lactobacillus buchneri Species 0.000 claims description 20
- 244000199866 Lactobacillus casei Species 0.000 claims description 20
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 20
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 20
- 241000194108 Bacillus licheniformis Species 0.000 claims description 19
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 19
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 19
- 241000193171 Clostridium butyricum Species 0.000 claims description 19
- 241000194031 Enterococcus faecium Species 0.000 claims description 19
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 19
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 19
- 241000031003 Monascus ruber Species 0.000 claims description 19
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 19
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 19
- 229940017800 lactobacillus casei Drugs 0.000 claims description 19
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 18
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 18
- 241001134659 Lactobacillus curvatus Species 0.000 claims description 18
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 18
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 18
- 235000013557 nattō Nutrition 0.000 claims description 18
- 240000001929 Lactobacillus brevis Species 0.000 claims description 17
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 17
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 17
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 17
- 241000193749 Bacillus coagulans Species 0.000 claims description 16
- 244000057717 Streptococcus lactis Species 0.000 claims description 16
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 16
- 244000068988 Glycine max Species 0.000 claims description 15
- 235000010469 Glycine max Nutrition 0.000 claims description 15
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 15
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 15
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 15
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 15
- 229940006091 aloe polysaccharide Drugs 0.000 claims description 15
- 229940054340 bacillus coagulans Drugs 0.000 claims description 15
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 15
- 229920001542 oligosaccharide Polymers 0.000 claims description 15
- 150000002482 oligosaccharides Chemical class 0.000 claims description 15
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 15
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 14
- 229920002752 Konjac Polymers 0.000 claims description 14
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 14
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 14
- 150000004676 glycans Chemical class 0.000 claims description 14
- 229920001282 polysaccharide Polymers 0.000 claims description 14
- 239000005017 polysaccharide Substances 0.000 claims description 14
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 13
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 13
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 13
- 235000010485 konjac Nutrition 0.000 claims description 13
- 239000000252 konjac Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 10
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 8
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 3
- 239000000865 liniment Substances 0.000 claims description 3
- 229940040145 liniment Drugs 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 4
- 235000007516 Chrysanthemum Nutrition 0.000 claims 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 239000003053 toxin Substances 0.000 abstract description 10
- 231100000765 toxin Toxicity 0.000 abstract description 10
- 230000032683 aging Effects 0.000 abstract description 5
- 150000003254 radicals Chemical class 0.000 abstract description 5
- 230000007413 intestinal health Effects 0.000 abstract description 4
- 244000052616 bacterial pathogen Species 0.000 abstract description 3
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 230000004888 barrier function Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 230000000529 probiotic effect Effects 0.000 abstract description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 12
- 210000000481 breast Anatomy 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 241000726221 Gemma Species 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000013351 cheese Nutrition 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 241001478240 Coccus Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 235000021168 barbecue Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001449625 Lactobacillus plantarum 16 Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 241000261238 bacterium 1.5 Species 0.000 description 1
- 241000261152 bacterium 3.8 Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019722 synbiotics Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000000647 trehalose group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/121—Brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/133—Curvatus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/157—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/41—Pediococcus
- A23V2400/413—Acidilactici
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application, anti-oxidant, anti-aging the symphysis unit composition includes prebiotics and probiotics, and the weight ratio of the prebiotics and probiotics is 1~10：1~10.The symphysis unit composition of the present invention can both play the physiological bacterial activity of probiotics, and cooperation prebiotics optionally quickly increase the quantity of probiotics again, make that probiotic action speed is fast and effect is lasting, to play the physiological function of probiotics and prebiotics simultaneously.The symphysis unit of the present invention effectively facilitates intestinal health; remove toxin; protect intestinal mucosa; mycoderm barrier is maintained, a large amount of harmful substances such as bacterium and toxin in enteron aisle are confined in enteric cavity, while inhibiting the generation of pathogenic bacteria and toxin; remove toxin; intestinal health is kept, the generation of free radical is reduced, to slow down aging.
Description
Technical field
The invention belongs to microbe additive technical fields, and in particular to a kind of anti-oxidant, anti-aging symphysis unit combination
Object and its preparation and application.
Background technology
Symphysis unit is also known as Synbiotics or symbiosis member, is the composite article of probiotics and prebiotics.Probiotics is one kind to place
Main beneficial active microorganism.And prebiotics refer to a kind of food ingredients that beneficial bacterium can be promoted to grow or substance, be it is a kind of not
Easily by the growth of beneficial bacterium or the active beneficial bacteria product of enhancing beneficial bacterium in human consumption but alternative stimulation enteron aisle.
Now in the art, have the relevant report of symphysis unit, but be formulated mostly unreasonable, be unable to reach preferable work(
Effect, What is more, and good promotion improvement result cannot be played to internal beneficial flora.And existing symphysis unit composition
Specific aim is not strong, and effect is barely satisfactory.
People are in daily life due to inherent or external, or with advancing age, body interior free yl by
Cumulative more, the ability of cell clearance free radical gradually declines, and then causes various damage accumulations, directly causes human senility.Skin
Skin is body aging one of organ the most apparent in the process, and with advancing age, thinning of skin, water content can occur for skin
The symptoms such as reduction, tissue elasticity attenuating, atrophy, corrugation.And particularly with white collar crowd, due to being frequently necessary to be sitting in computer for a long time
Before, cause enteron aisle unhealthy, the toxin of body has no idea normally to exclude, and interior free yl accumulation, excessive free radical is attacked
Skin Cell is hit, causes skin aging, face turns yellow, spot and flaw increase.In addition to this, it is also to accelerate people that diet is unhealthy
The one of the major reasons of body aging may all add a large amount of man-made additive in existing many foods, and such food is taken the photograph
Membership causes body to will produce polyradical, destroys cell.In addition barbecue, barbecue, the edible of maror also exacerbate people
The aging of body.
For this purpose, a kind of product that can be solved the above problems of research and development is very important.
Invention content
The first object of the present invention is to provide a kind of anti-oxidant, anti-aging symphysis unit composition, the second object of the present invention
It is to provide a kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the third object of the present invention is to provide a kind of anti-
It aoxidizes, the application of the symphysis unit composition of anti-aging.
The first object of the present invention is achieved in that anti-oxidant, anti-aging the symphysis unit composition includes benefit
The weight ratio of raw member and probiotics, the prebiotics and probiotics is 1~10：1~10.
Preferably, the weight ratio of the prebiotics and probiotics is 3~10：1.
Preferably, the weight ratio of the prebiotics and probiotics is 1：1~7.
Preferably, the prebiotics include the ingredient of following weight percent：Trehalose 6~9%, raffinose 1~
4%, xylo-oligosaccharide 14~17%, oligoisomaltose 1~4%, oligofructose 6~9%, galactooligosaccharide 0.5~2.5%,
Chitosan oligosaccharide 6~9%, soyabean oligosaccharides 5~8%, synanthrin 13~16%, aloe polysaccharide 8~11%, konjac polysaccharide 24~27%.
Preferably, the prebiotics include the ingredient of following weight percent：Trehalose 7~8%, raffinose 2~
3%, xylo-oligosaccharide 15~16%, oligoisomaltose 2~3%, oligofructose 7~8%, galactooligosaccharide 1~2%, shell are few
Sugar 7~8%, soyabean oligosaccharides 6~7%, synanthrin 14~15%, aloe polysaccharide 9~10%, konjac polysaccharide 25~26%.
Preferably, the probiotics includes the ingredient of following weight percent：Lactobacillus acidophilus 0.5~3%, short newborn bar
It is bacterium 0.4~1.2%, lactobacillus buchneri 0.4~1.2%, Lactobacillus casei 7~27%, Lactobacillus paracasei 0.5~2.5%, curved
Bent lactobacillus 0.4~1.2%, lactobacillus bulgaricus 0.4~1.2%, Lactobacillus delbrueckii 0.4~1.2%, lactobacillus plantarum 14
~57.9%, Lactobacillus salivarius 0.4~1.2%, bacillus subtilis 0~30%, bacillus licheniformis 0~8%, condensation gemma
Bacillus 0~6%, bafillus natto 0~8%, bifidobacterium adolescentis 0.4~1.2%, bifidobacterium bifidum 0.4~1.2%,
Enterococcus faecalis 0~1.2%, enterococcus faecium 0~5%, Lactococcus lactis 0~5%, clostridium butyricum 0~2.5%, Pediococcus acidilactici 0
~2.5%, monascus ruber 0~10%.
Preferably, the probiotics includes the ingredient of following weight percent：Lactobacillus acidophilus 0.5~3%, short newborn bar
It is bacterium 0.4~1.2%, lactobacillus buchneri 0.4~1.2%, Lactobacillus casei 7~9%, Lactobacillus paracasei 0.5~2.5%, curved
Bent lactobacillus 0.4~1.2%, lactobacillus bulgaricus 0.4~1.2%, Lactobacillus delbrueckii 0.4~1.2%, lactobacillus plantarum 14
~17%, Lactobacillus salivarius 0.4~1.2%, bacillus subtilis 27~30%, bacillus licheniformis 5~8%, condensation gemma
Bacillus 3~6%, bafillus natto 5~8%, bifidobacterium adolescentis 0.4~1.2%, bifidobacterium bifidum 0.4~1.2%,
Enterococcus faecalis 0.4~1.2%, enterococcus faecium 2~5%, Lactococcus lactis 2~5%, clostridium butyricum 0.5~2.5%, lactic acid sheet
Coccus 0.5~2.5%, monascus ruber 7~10%.
Preferably, the probiotics includes the ingredient of following weight percent：Lactobacillus acidophilus 1~2%, Lactobacillus brevis
0.6~1%, lactobacillus buchneri 0.6~1%, Lactobacillus casei 8~9%, Lactobacillus paracasei 1~2%, lactobacillus curvatus 0.6
~1%, lactobacillus bulgaricus 0.6~1%, Lactobacillus delbrueckii 0.6~1%, lactobacillus plantarum 15~16%, Lactobacillus salivarius
0.6~1%, bacillus subtilis 28~29%, bacillus licheniformis 6~7%, bacillus coagulans 4~5%, natto gemma
Bacillus 6~7%, bifidobacterium adolescentis 0.6~1%, bifidobacterium bifidum 0.6~1%, enterococcus faecalis 0.6~1%, dung intestines ball
Bacterium 3~4%, Lactococcus lactis 3~4%, clostridium butyricum 1~2%, Pediococcus acidilactici 1~2%, monascus ruber 8~9%.
The second object of the present invention is achieved in that the preparation is that medicine is added in the symphysis unit composition
Powder, tablet, granule, capsule, liquid preparation, liniment is made in acceptable auxiliary material on.
The third object of the present invention is achieved in that prepared by anti-oxidant, anti-aging the symphysis unit composition
Application in anti-oxidant, anti-aging drug, health food or skin care item.
The instructions of taking of anti-oxidant, anti-aging symphysis unit composition of the present invention, the instructions of taking are one
Day 1~2 time, 10~20g every time.
The entitled Lactobacillus acidophilus of Latin of the lactobacillus acidophilus.
The entitled Lactobacillus breris of Latin of the Lactobacillus brevis.
The entitled Lactobacillus buchneri of Latin of the lactobacillus buchneri.
The entitled L.casei of Latin of the Lactobacillus casei.
The entitled L.paracasei of Latin of the Lactobacillus paracasei.
The entitled L.curvatus of Latin of the lactobacillus curvatus.
The entitled L.bulbaricus of Latin of the lactobacillus bulgaricus.
The entitled L.debrueckii of Latin of the Lactobacillus delbrueckii.
The entitled L.plantarum of Latin of the lactobacillus plantarum.
The entitled L.salivarius of Latin of the Lactobacillus salivarius.
The entitled Bacillus subtilis of Latin of the bacillus subtilis.
The entitled B.lincheniformis of Latin of the bacillus licheniformis.
The entitled B.coagulans of Latin of the bacillus coagulans.
The entitled B.natto of Latin of the bafillus natto.
The entitled B.adolescebntils of Latin of the bifidobacterium adolescentis.
The entitled B.bifidum of Latin of the bifidobacterium bifidum.
The entitled Enterococcusfaecalis of Latin of the enterococcus faecalis.
The entitled E.faecium of Latin of the enterococcus faecium.
The entitled Lactococus lactis of Latin of the Lactococcus lactis.
The entitled Clostridium butyricum of Latin of the clostridium butyricum.
The entitled Pediococcus acidilactici of Latin of the Pediococcus acidilactici.
The entitled Monascuspurpureus of Latin of the monascus ruber.
Compared with prior art, beneficial effects of the present invention：
1, symphysis unit composition of the invention effectively enhances effect by the rational proportion between probiotics and prebiotics, prebiotic
Member can be effectively increased the probiotics quantity in composition, extend the term of validity of symphysis unit, not only so that its is efficacy lasting, but also
Promote survival rate of the probiotics in enteron aisle, and prebiotics can digest while as external source probio food entering
The competitive growth for promoting exogenous probiotics and endogenous probiotics after system simultaneously, inhibits pathogenic bacteria therein, realizes
The effect of removing gastrointestinal tract toxin, reduces the generation of free radical, anti-aging.
2, symphysis unit composition of the present invention can effectively reduce the generation of interior free yl, slow down aging, pass through science
The combination of selection probiotics and prebiotics and composition proportion appropriate make the symphysis unit composition clear efficacy notable, at
Divide safely and effectively, material matching is reasonable.
3, symphysis unit of the invention effectively facilitates intestinal health, removes toxin, protects intestinal mucosa, maintains mycoderm barrier, will
The a large amount of harmful substances such as bacterium and toxin are confined in enteric cavity in enteron aisle, while inhibiting the generation of pathogenic bacteria and toxin, are removed
Toxin keeps intestinal health, reduces the generation of free radical.
4, the present invention obtains the material composition proportioning of science through a large number of experiments, is targetedly selected according to application crowd
The optimum composition method for selecting probiotics and prebiotics, by scientific and effective proportioning so that symphysis unit composition performance is maximum
Effect so that the present invention can not only effectively realize its effect, and selected prebiotics can the benefit arranged in pairs or groups of effective stimulus
Raw bacterium proliferation, reasonable composition.
5, instructions of taking dosage of the invention is reasonable, and obvious effect effectively prevents existing probiotics preparation dosage not
It to no effect or takes after being taken caused by clear and is excessively possible to the ill effect brought.
6, symphysis unit composition of the invention can both play the physiological bacterial activity of probiotics, and cooperation prebiotics are again optional
The quantity for quickly increasing to selecting property probiotics, makes that probiotic action speed is fast and effect is lasting, to play simultaneously probiotics and
The physiological function of prebiotics；The present invention also has the advantages that significant effect, quick, safe.
Specific implementation mode
With reference to embodiment, the present invention is further illustrated, but is not limited in any way to the present invention,
Based on present invention teach that made by it is any transform or replace, all belong to the scope of protection of the present invention.
Embodiment 1
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 1：10.
Embodiment 2
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 10：1.
Embodiment 3
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 9：2.
Embodiment 4
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 2：9.
Embodiment 5
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 7.5：3.
Embodiment 6
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 3：7.5.
Embodiment 7
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 5：4.
Embodiment 8
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 3：1.
Embodiment 9
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 1：7.
Embodiment 10
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, the prebiotics and probiotics
Weight ratio is 1：1.
Embodiment 11
Anti-oxidant, anti-aging symphysis unit composition as described in Example 1, the prebiotics include following weight percent
Ingredient：Trehalose 6%, raffinose 1%, xylo-oligosaccharide 14%, oligoisomaltose 1%, oligofructose 6%, oligomeric gala
Sugar 1%, chitosan oligosaccharide 9%, soyabean oligosaccharides 8%, synanthrin 16%, aloe polysaccharide 11%, konjac polysaccharide 27%.
Embodiment 12
Anti-oxidant, anti-aging symphysis unit composition as described in Example 2, the prebiotics include following weight percent
Ingredient：Trehalose 9%, raffinose 4%, xylo-oligosaccharide 17%, oligoisomaltose 4%, oligofructose 9%, oligomeric gala
Sugar 1%, chitosan oligosaccharide 6%, soyabean oligosaccharides 5%, synanthrin 13%, aloe polysaccharide 8%, konjac polysaccharide 24%.
Embodiment 13
Anti-oxidant, anti-aging symphysis unit composition as described in Example 3, the prebiotics include following weight percent
Ingredient：Trehalose 7.3%, raffinose 2.4%, xylo-oligosaccharide 15.9%, oligoisomaltose 2.4%, oligofructose
7.3%, galactooligosaccharide 1.2%, chitosan oligosaccharide 7.3%, soyabean oligosaccharides 6.1%, synanthrin 14.6%, aloe polysaccharide 9.8%, evil spirit
Taro polysaccharide 25.6%.
Embodiment 14
Anti-oxidant, anti-aging symphysis unit composition as described in Example 4, the prebiotics include following weight percent
Ingredient：Trehalose 7%, raffinose 2%, xylo-oligosaccharide 15%, oligoisomaltose 2%, oligofructose 7%, oligomeric gala
Sugar 1%, chitosan oligosaccharide 8%, soyabean oligosaccharides 7%, synanthrin 15%, aloe polysaccharide 10%, konjac polysaccharide 26%.
Embodiment 15
Anti-oxidant, anti-aging symphysis unit composition as described in Example 5, the prebiotics include following weight percent
Ingredient：Trehalose 8%, raffinose 3%, xylo-oligosaccharide 16%, oligoisomaltose 3%, oligofructose 8%, oligomeric gala
Sugar 1%, chitosan oligosaccharide 7%, soyabean oligosaccharides 6%, synanthrin 14%, aloe polysaccharide 9%, konjac polysaccharide 25%.
Embodiment 16
Anti-oxidant, anti-aging symphysis unit composition as described in Example 6, the prebiotics include following weight percent
Ingredient：Trehalose 8.5%, raffinose 3.5%, xylo-oligosaccharide 15.9%, oligoisomaltose 3.5%, oligofructose
7.3%, galactooligosaccharide 0.5%, chitosan oligosaccharide 7.3%, soyabean oligosaccharides 6.9%, synanthrin 13%, aloe polysaccharide 8%, konjaku are more
Sugar 25.6%.
Embodiment 17
Anti-oxidant, anti-aging symphysis unit composition as described in Example 7, the prebiotics include following weight percent
Ingredient：Trehalose 8%, raffinose 4%, xylo-oligosaccharide 17%, oligoisomaltose 2.4%, oligofructose 9%, oligomeric half
Lactose 2.5%, chitosan oligosaccharide 6%, soyabean oligosaccharides 6.1%, synanthrin 13%, aloe polysaccharide 8%, konjac polysaccharide 24%.
Embodiment 18
Anti-oxidant, anti-aging symphysis unit composition as described in Example 8, the prebiotics include following weight percent
Ingredient：Trehalose 7%, raffinose 2%, xylo-oligosaccharide 15%, oligoisomaltose 2%, oligofructose 7%, oligomeric gala
Sugar 1.2%, chitosan oligosaccharide 8%, soyabean oligosaccharides 7%, synanthrin 15%, aloe polysaccharide 9.8%, konjac polysaccharide 26%.
Embodiment 19
Anti-oxidant, anti-aging symphysis unit composition as described in Example 9, the prebiotics include following weight percent
Ingredient：It is trehalose 7.5%, raffinose 2.1%, xylo-oligosaccharide 15%, oligoisomaltose 2%, oligofructose 7%, oligomeric
Galactolipin 2%, chitosan oligosaccharide 8%, soyabean oligosaccharides 6.1%, synanthrin 14.6%, aloe polysaccharide 9.7%, konjac polysaccharide 26%.
Embodiment 20
Anti-oxidant, anti-aging symphysis unit composition as described in Example 10, the prebiotics include following weight percent
The ingredient of ratio：Trehalose 7.3%, raffinose 2.1%, xylo-oligosaccharide 15%, oligoisomaltose 2%, oligofructose 7.1%,
Galactooligosaccharide 1.5%, chitosan oligosaccharide 8%, soyabean oligosaccharides 5.8%, synanthrin 15.5%, aloe polysaccharide 9.7%, konjac polysaccharide
26%.
Embodiment 21
A kind of anti-oxidant, anti-aging symphysis unit composition, the prebiotics include the ingredient of following weight percent：Seaweed
Sugar 6.5%, raffinose 2.4%, xylo-oligosaccharide 16.5%, oligoisomaltose 3.5%, oligofructose 6.5%, galactooligosaccharide
1.5%, chitosan oligosaccharide 6.5%, soyabean oligosaccharides 6%, synanthrin 14.8%, aloe polysaccharide 9.7%, konjac polysaccharide 26.1%.
Embodiment 22
Anti-oxidant, anti-aging symphysis unit composition as described in Example 1, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 0.5%, Lactobacillus brevis 0.4%, lactobacillus buchneri 0.4%, Lactobacillus casei 7%, secondary cheese breast bar
Bacterium 0.5%, lactobacillus curvatus 0.4%, lactobacillus bulgaricus 0.4%, Lactobacillus delbrueckii 0.4%, lactobacillus plantarum 14%, saliva
Liquid lactobacillus 0.4%, bacillus subtilis 27%, bacillus licheniformis 6%, bacillus coagulans 6%, bafillus natto
8%, bifidobacterium adolescentis 1.2%, bifidobacterium bifidum 1.2%, enterococcus faecalis 1.2%, enterococcus faecium 5%, Lactococcus lactis
5%, clostridium butyricum 2.5%, Pediococcus acidilactici 2.5%, monascus ruber 10%.
Embodiment 23
Anti-oxidant, anti-aging symphysis unit composition as described in Example 2, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 3%, Lactobacillus brevis 1.2%, lactobacillus buchneri 1.2%, Lactobacillus casei 9%, Lactobacillus paracasei
2.5%, lactobacillus curvatus 1.2%, lactobacillus bulgaricus 1.2%, Lactobacillus delbrueckii 1.2%, lactobacillus plantarum 17%, saliva
Lactobacillus 1.2%, bacillus subtilis 30%, bacillus licheniformis 8%, bacillus coagulans 5.1%, bafillus natto
5%, bifidobacterium adolescentis 0.4%, bifidobacterium bifidum 0.4%, enterococcus faecalis 0.4%, enterococcus faecium 2%, Lactococcus lactis
2%, clostridium butyricum 0.5%, Pediococcus acidilactici 0.5%, monascus ruber 7%.
Embodiment 24
Anti-oxidant, anti-aging symphysis unit composition as described in Example 3, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 1.5%, Lactobacillus brevis 0.8%, lactobacillus buchneri 0.8%, Lactobacillus casei 8%, secondary cheese breast bar
Bacterium 1.5%, lactobacillus curvatus 0.8%, lactobacillus bulgaricus 0.8%, Lactobacillus delbrueckii 0.8%, lactobacillus plantarum 15.5%,
Lactobacillus salivarius 0.8%, bacillus subtilis 28.5%, bacillus licheniformis 7%, bacillus coagulans 4.5%, natto gemma
Bacillus 6.5%, bifidobacterium adolescentis 0.8%, bifidobacterium bifidum 0.8%, enterococcus faecalis 0.8%, enterococcus faecium 3.5%, breast
Yogurt coccus 3.5%, clostridium butyricum 1.5%, Pediococcus acidilactici 1.5%, monascus ruber 9.8%.
Embodiment 25
Anti-oxidant, anti-aging symphysis unit composition as described in Example 4, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 1%, Lactobacillus brevis 0.6%, lactobacillus buchneri 0.6%, Lactobacillus casei 8%, Lactobacillus paracasei
1%, lactobacillus curvatus 0.6%, lactobacillus bulgaricus 0.6%, Lactobacillus delbrueckii 0.6%, lactobacillus plantarum 15%, saliva breast
Bacillus 0.6%, bacillus subtilis 28.4%, bacillus licheniformis 7%, bacillus coagulans 5%, bafillus natto 7%,
Bifidobacterium adolescentis 1%, bifidobacterium bifidum 1%, enterococcus faecalis 1%, enterococcus faecium 4%, Lactococcus lactis 4%, butyric acid shuttle
Bacterium 2%, Pediococcus acidilactici 2%, monascus ruber 9%.
Embodiment 26
Anti-oxidant, anti-aging symphysis unit composition as described in Example 5, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 2%, Lactobacillus brevis 1%, lactobacillus buchneri 1%, Lactobacillus casei 9%, Lactobacillus paracasei 2%,
It is lactobacillus curvatus 1%, lactobacillus bulgaricus 1%, Lactobacillus delbrueckii 1%, lactobacillus plantarum 16%, Lactobacillus salivarius 1%, withered
Careless bacillus 29%, bacillus licheniformis 7%, bacillus coagulans 5.2%, bafillus natto 6%, bifidobacterium adolescentis
0.6%, bifidobacterium bifidum 0.6%, enterococcus faecalis 0.6%, enterococcus faecium 3%, Lactococcus lactis 3%, clostridium butyricum 1%,
Pediococcus acidilactici 1%, monascus ruber 8%.
Embodiment 27
Anti-oxidant, anti-aging symphysis unit composition as described in Example 6, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 2.5%, Lactobacillus brevis 0.4%, lactobacillus buchneri 0.4%, Lactobacillus casei 8.4%, secondary cheese breast
Bacillus 0.5%, lactobacillus curvatus 0.4%, lactobacillus bulgaricus 0.4%, Lactobacillus delbrueckii 0.4%, lactobacillus plantarum
16.5%, Lactobacillus salivarius 0.4%, bacillus subtilis 29.5%, bacillus licheniformis 5%, bacillus coagulans 5.5%,
Bafillus natto 7.5%, bifidobacterium adolescentis 0.4%, bifidobacterium bifidum 0.4%, enterococcus faecalis 0.4%, enterococcus faecium
4.5%, Lactococcus lactis 4.5%, clostridium butyricum 2%, Pediococcus acidilactici 1.6%, monascus ruber 8.4%.
Embodiment 28
Anti-oxidant, anti-aging symphysis unit composition as described in Example 7, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 0.5%, Lactobacillus brevis 0.4%, lactobacillus buchneri 0.4%, Lactobacillus casei 7.5%, secondary cheese breast
Bacillus 2.5%, lactobacillus curvatus 0.4%, lactobacillus bulgaricus 0.4%, Lactobacillus delbrueckii 0.4%, lactobacillus plantarum
15.3%, Lactobacillus salivarius 1.2%, bacillus subtilis 28.7%, bacillus licheniformis 8%, bacillus coagulans 3%, receive
Beans bacillus 8%, bifidobacterium adolescentis 0.4%, bifidobacterium bifidum 0.4%, enterococcus faecalis 0.4%, enterococcus faecium
3.8%, Lactococcus lactis 3.8%, clostridium butyricum 2.5%, Pediococcus acidilactici 2%, monascus ruber 10%.
Embodiment 29
Anti-oxidant, anti-aging symphysis unit composition as described in Example 8, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 1%, Lactobacillus brevis 0.65%, lactobacillus buchneri 0.65%, Lactobacillus casei 8.5%, secondary cheese breast
Bacillus 1%, lactobacillus curvatus 0.9%, lactobacillus bulgaricus 0.9%, Lactobacillus delbrueckii 0.9%, lactobacillus plantarum 16.5%,
Lactobacillus salivarius 0.9%, bacillus subtilis 28%, bacillus licheniformis 6.9%, bacillus coagulans 4%, natto gemma bar
Bacterium 6.9%, bifidobacterium adolescentis 0.9%, bifidobacterium bifidum 0.9%, enterococcus faecalis 0.9%, enterococcus faecium 4.5%, lactic acid
Galactococcus 4.5%, clostridium butyricum 1.3%, Pediococcus acidilactici 1.3%, monascus ruber 8%.
Embodiment 30
Anti-oxidant, anti-aging symphysis unit composition as described in Example 9, the probiotics includes following weight percent
Ingredient：Lactobacillus acidophilus 2%, Lactobacillus brevis 1%, lactobacillus buchneri 1%, Lactobacillus casei 8.4%, Lactobacillus paracasei
1.5%, lactobacillus curvatus 0.8%, lactobacillus bulgaricus 0.8%, Lactobacillus delbrueckii 0.8%, lactobacillus plantarum 15.3%, saliva
Liquid lactobacillus 0.8%, bacillus subtilis 29%, bacillus licheniformis 7%, bacillus coagulans 4%, bafillus natto
7%, bifidobacterium adolescentis 0.8%, bifidobacterium bifidum 0.8%, enterococcus faecalis 0.8%, enterococcus faecium 3.8%, Lactococcus lactis
Bacterium 3.8%, clostridium butyricum 1.5%, Pediococcus acidilactici 1%, monascus ruber 8.1%.
Embodiment 31
Anti-oxidant, anti-aging symphysis unit composition as described in Example 10, the probiotics includes following weight percent
The ingredient of ratio：Lactobacillus acidophilus 2%, Lactobacillus brevis 1%, lactobacillus buchneri 1%, Lactobacillus casei 8%, Lactobacillus paracasei
1.5%, lactobacillus curvatus 1%, lactobacillus bulgaricus 1%, Lactobacillus delbrueckii 0.8%, lactobacillus plantarum 15.5%, saliva breast
Bacillus 0.8%, bacillus subtilis 28.5%, bacillus licheniformis 7%, bacillus coagulans 4.5%, bafillus natto
6.5%, bifidobacterium adolescentis 0.8%, bifidobacterium bifidum 0.8%, enterococcus faecalis 0.8%, enterococcus faecium 3.5%, lactic acid breast
Coccus 3.5%, clostridium butyricum 1.5%, Pediococcus acidilactici 1.5%, monascus ruber 8.5%.
Embodiment 32
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, wherein the probiotics includes
The ingredient of following weight percent：Lactobacillus acidophilus 1.8%, Lactobacillus brevis 0.6%, lactobacillus buchneri 0.6%, Lactobacillus casei
8.4%, Lactobacillus paracasei 1.5%, lactobacillus curvatus 0.6%, lactobacillus bulgaricus 0.6%, Lactobacillus delbrueckii 0.6%,
Lactobacillus plantarum 15.4%, Lactobacillus salivarius 0.6%, bacillus subtilis 29%, bacillus licheniformis 7%, condensation gemma bar
Bacterium 4.6%, bafillus natto 7.5%, bifidobacterium adolescentis 0.6%, bifidobacterium bifidum 0.6%, enterococcus faecalis 0.6%,
Enterococcus faecium 4%, Lactococcus lactis 4%, clostridium butyricum 1.5%, Pediococcus acidilactici 1.5%, monascus ruber 8.4%.
Embodiment 33
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, wherein the probiotics includes
The ingredient of following weight percent：Lactobacillus acidophilus 2.5%, Lactobacillus brevis 1%, lactobacillus buchneri 1%, Lactobacillus casei
7.5%, Lactobacillus paracasei 2.5%, lactobacillus curvatus 1.2%, lactobacillus bulgaricus 1.2%, Lactobacillus delbrueckii 1.2%,
Lactobacillus plantarum 15.7%, Lactobacillus salivarius 0.9%, bacillus subtilis 28.8%, bacillus licheniformis 7.8%, condensation bud
Spore bacillus 4.8%, bafillus natto 6.8%, bifidobacterium adolescentis 1.1%, bifidobacterium bifidum 1.1%, enterococcus faecalis
1.1%, enterococcus faecium 3.6%, Lactococcus lactis 2.2%, clostridium butyricum 0.5%, Pediococcus acidilactici 0.5%, monascus ruber
7%.
Embodiment 34
A kind of anti-oxidant, anti-aging symphysis unit composition, including prebiotics and probiotics, wherein the probiotics includes
The ingredient of following weight percent：Lactobacillus acidophilus 3%, Lactobacillus brevis 1.2%, lactobacillus buchneri 1.2%, Lactobacillus casei
27%, Lactobacillus paracasei 2.5%, lactobacillus curvatus 1.2%, lactobacillus bulgaricus 1.2%, Lactobacillus delbrueckii 1.2%, plant
Object lactobacillus 57.9%, Lactobacillus salivarius 1.2%, bacillus subtilis 0%, bacillus licheniformis 0%, bacillus coagulans
0%, bafillus natto 0%, bifidobacterium adolescentis 1.2%, bifidobacterium bifidum 1.2%, enterococcus faecalis 0%, enterococcus faecium
0%, Lactococcus lactis 0%, clostridium butyricum 0%, Pediococcus acidilactici 0%, monascus ruber 0%.
Embodiment 35
A kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the preparation are described anti-oxidant, anti-aging
Pharmaceutically acceptable auxiliary material is added in symphysis unit composition, powder is made.
Application of anti-oxidant, anti-aging the symphysis unit composition in preparing oxidation resistant drug.
Embodiment 36
A kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the preparation are described anti-oxidant, anti-aging
Pharmaceutically acceptable auxiliary material is added in symphysis unit composition, tablet is made.
Application of anti-oxidant, anti-aging the symphysis unit composition in preparing oxidation-resisting health-care food.
Embodiment 37
A kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the preparation are described anti-oxidant, anti-aging
Pharmaceutically acceptable auxiliary material is added in symphysis unit composition, granule is made.
Application of anti-oxidant, anti-aging the symphysis unit composition in preparing oxidation resistant skin care item.
Embodiment 38
A kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the preparation are described anti-oxidant, anti-aging
Pharmaceutically acceptable auxiliary material is added in symphysis unit composition, capsule is made.
Application of anti-oxidant, anti-aging the symphysis unit composition in the drug for preparing anti-aging.
Embodiment 39
A kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the preparation are described anti-oxidant, anti-aging
Pharmaceutically acceptable auxiliary material is added in symphysis unit composition, liquid preparation is made.
Application of anti-oxidant, anti-aging the symphysis unit composition in the health food for preparing anti-aging.
Embodiment 40
A kind of preparation of anti-oxidant, anti-aging symphysis unit composition, the preparation are described anti-oxidant, anti-aging
Pharmaceutically acceptable auxiliary material is added in symphysis unit composition, liniment is made.
Application of anti-oxidant, anti-aging the symphysis unit composition in the skin care item for preparing anti-aging.
Embodiment 41
Experimental example：Wu so-and-so, female, Zhaotong County, Yunnan people, 48 years old, skin of face color spot was apparent, uninterruptedly takes the present invention and prepares
Symphysis unit composition tablet, two times a day, each 10g, after taking 60 days, facial colour spot is obviously desalinated, and naked eyes hardly may be used
See.
Embodiment 42
Experimental example：So-and-so is applied, female, Yunnan people from Pu'er, 53 years old, complexion was obviously turned to be yellow, and uninterruptedly took symphysis prepared by the present invention
First composition capsule, once a day, each 20g, after taking 90 days, complexion turn to be yellow the problem of thoroughly solve, having rosy cheeks has
Gloss.
Embodiment 43
Experimental example：Mr. Li, male, Honghe, Yunnan people, 63 years old, senile plaque uninterruptedly took symphysis unit combination prepared by the present invention
Composition granule agent, 2 times a day, a 15g, after being used continuously 90 days, situation is clearly better, and senile plaque desalination has no new old age
Spot generates.
Claims (10)
1. a kind of anti-oxidant, anti-aging symphysis unit composition, it is characterised in that anti-oxidant, anti-aging the symphysis tuple
It includes prebiotics and probiotics to close object, and the weight ratio of the prebiotics and probiotics is 1~10：1~10.
2. anti-oxidant, anti-aging symphysis unit composition according to claim 1, it is characterised in that the prebiotics with
The weight ratio of probiotics is 3~10：1.
3. anti-oxidant, anti-aging symphysis unit composition according to claim 1, it is characterised in that the prebiotics with
The weight ratio of probiotics is 1：1~7.
4. anti-oxidant, anti-aging symphysis unit composition according to claim 1, it is characterised in that the prebiotics packet
Include the ingredient of following weight percent：Trehalose 6~9%, raffinose 1~4%, xylo-oligosaccharide 14~17%, oligomeric different malt
Sugar 1~4%, oligofructose 6~9%, galactooligosaccharide 0.5~2.5%, chitosan oligosaccharide 6~9%, soyabean oligosaccharides 5~8%, chrysanthemum
Sugar 13~16%, aloe polysaccharide 8~11%, konjac polysaccharide 24~27%.
5. anti-oxidant, anti-aging symphysis unit composition according to claim 1, it is characterised in that the prebiotics packet
Include the ingredient of following weight percent：Trehalose 7~8%, raffinose 2~3%, xylo-oligosaccharide 15~16%, oligomeric different malt
Sugar 2~3%, oligofructose 7~8%, galactooligosaccharide 1~2%, chitosan oligosaccharide 7~8%, soyabean oligosaccharides 6~7%, synanthrin 14
~15%, aloe polysaccharide 9~10%, konjac polysaccharide 25~26%.
6. anti-oxidant, anti-aging symphysis unit composition according to claim 1, it is characterised in that the prebiotic bacterium bag
Include the ingredient of following weight percent：Lactobacillus acidophilus 0.5~3%, Lactobacillus brevis 0.4~1.2%, lactobacillus buchneri 0.4~
1.2%, Lactobacillus casei 7~27%, Lactobacillus paracasei 0.5~2.5%, lactobacillus curvatus 0.4~1.2%, Bulgaria
Lactobacillus 0.4~1.2%, Lactobacillus delbrueckii 0.4~1.2%, lactobacillus plantarum 14~57.9%, Lactobacillus salivarius 0.4~
1.2%, bacillus subtilis 0~30%, bacillus licheniformis 0~8%, bacillus coagulans 0~6%, bafillus natto 0
~8%, bifidobacterium adolescentis 0.4~1.2%, bifidobacterium bifidum 0.4~1.2%, enterococcus faecalis 0~1.2%, enterococcus faecium
0~5%, Lactococcus lactis 0~5%, clostridium butyricum 0~2.5%, Pediococcus acidilactici 0~2.5%, monascus ruber 0~10%.
7. anti-oxidant, anti-aging symphysis unit composition according to claim 1, it is characterised in that the prebiotic bacterium bag
Include the ingredient of following weight percent：Lactobacillus acidophilus 1~2%, Lactobacillus brevis 0.6~1%, lactobacillus buchneri 0.6~1%,
Lactobacillus casei 8~9%, Lactobacillus paracasei 1~2%, lactobacillus curvatus 0.6~1%, lactobacillus bulgaricus 0.6~
1%, Lactobacillus delbrueckii 0.6~1%, lactobacillus plantarum 15~16%, Lactobacillus salivarius 0.6~1%, bacillus subtilis 28~
29%, bacillus licheniformis 6~7%, bacillus coagulans 4~5%, bafillus natto 6~7%, bifidobacterium adolescentis 0.6
~1%, bifidobacterium bifidum 0.6~1%, enterococcus faecalis 0.6~1%, enterococcus faecium 3~4%, Lactococcus lactis 3~4%,
Clostridium butyricum 1~2%, Pediococcus acidilactici 1~2%, monascus ruber 8~9%.
8. a kind of preparation according to any anti-oxidant, anti-aging the symphysis unit composition of claim 1~7, feature
It is that the preparation is that pharmaceutically acceptable auxiliary material is added in anti-oxidant, anti-aging the symphysis unit composition
Powder, tablet, granule, capsule, liquid preparation, liniment is made.
9. a kind of application according to any anti-oxidant, anti-aging the symphysis unit composition of claim 1~7, feature
It is that anti-oxidant, anti-aging the symphysis unit composition is preparing anti-oxidant, anti-aging drug, health food or skin care
Application in product.
10. a kind of instructions of taking according to any anti-oxidant, anti-aging the symphysis unit composition of claim 1~7,
It is characterized in that the instructions of taking of anti-oxidant, anti-aging the symphysis unit composition is 1~2 time on the one, every time 10~20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810104943.7A CN108576823A (en) | 2018-02-02 | 2018-02-02 | A kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810104943.7A CN108576823A (en) | 2018-02-02 | 2018-02-02 | A kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108576823A true CN108576823A (en) | 2018-09-28 |
Family
ID=63608937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810104943.7A Withdrawn CN108576823A (en) | 2018-02-02 | 2018-02-02 | A kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108576823A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020082220A1 (en) * | 2018-10-23 | 2020-04-30 | 利时雨 | Enterococcus faecalis having resistance to cephalosporin and high expression of sirtuin 2-like protein and use thereof |
| CN112772932A (en) * | 2020-12-31 | 2021-05-11 | 然益科技(深圳)有限公司 | Anti-aging hair-nourishing probiotic powder and preparation method thereof |
| CN112998276A (en) * | 2021-02-01 | 2021-06-22 | 天津科技大学 | Synbiotic compound preparation for preventing diarrhea, intestinal leakage and sepsis caused by excessive ingestion of prebiotics, preparation method and application |
| CN114306393A (en) * | 2020-09-30 | 2022-04-12 | 王忠诚 | New medicine capable of treating cramp, strengthening body and delaying senility and its prepn |
| CN115349619A (en) * | 2022-08-09 | 2022-11-18 | 山东莺歌食品有限公司 | Probiotics and prebiotics peanut butter |
| CN116173075A (en) * | 2022-10-17 | 2023-05-30 | 西北农林科技大学 | Synbiotic composition for improving cognitive function based on clostridium sporogenes and application thereof |
-
2018
- 2018-02-02 CN CN201810104943.7A patent/CN108576823A/en not_active Withdrawn
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020082220A1 (en) * | 2018-10-23 | 2020-04-30 | 利时雨 | Enterococcus faecalis having resistance to cephalosporin and high expression of sirtuin 2-like protein and use thereof |
| CN114306393A (en) * | 2020-09-30 | 2022-04-12 | 王忠诚 | New medicine capable of treating cramp, strengthening body and delaying senility and its prepn |
| CN112772932A (en) * | 2020-12-31 | 2021-05-11 | 然益科技(深圳)有限公司 | Anti-aging hair-nourishing probiotic powder and preparation method thereof |
| CN112998276A (en) * | 2021-02-01 | 2021-06-22 | 天津科技大学 | Synbiotic compound preparation for preventing diarrhea, intestinal leakage and sepsis caused by excessive ingestion of prebiotics, preparation method and application |
| CN112998276B (en) * | 2021-02-01 | 2023-08-29 | 天津科技大学 | Synbiotic compound preparation for preventing diarrhea, intestinal leakage and sepsis caused by excessive intake of prebiotics, preparation method and application |
| CN115349619A (en) * | 2022-08-09 | 2022-11-18 | 山东莺歌食品有限公司 | Probiotics and prebiotics peanut butter |
| CN116173075A (en) * | 2022-10-17 | 2023-05-30 | 西北农林科技大学 | Synbiotic composition for improving cognitive function based on clostridium sporogenes and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108576823A (en) | A kind of anti-oxidant, anti-aging symphysis unit composition and its preparation and application | |
| Timmerman et al. | Monostrain, multistrain and multispecies probiotics—A comparison of functionality and efficacy | |
| CN108576822A (en) | A kind of symphysis unit composition and its preparation and application with strengthen immunity function | |
| JP6444358B2 (en) | Pharmaceutical composition containing pediococcus and method for reducing symptoms of digestive syndrome | |
| EP2990045B1 (en) | Bifidobacterium animalis subsp. lactis for use in decreasing abdominal pain in a postmenopausal woman | |
| CN112342175B (en) | Vaginal health probiotic composition and application thereof | |
| TW201834673A (en) | Probiotic compositions comprising hericium erinaceus | |
| BRPI1011277B1 (en) | BACTERIOCINE PRODUCT LACTOBACILLUS PENTOSUS, FOOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USE OF THE SAME | |
| Papizadeh et al. | Lactobacillus rhamnosus Gorbach-Goldin (GG): A top well-researched probiotic strain | |
| MX2012011270A (en) | Animal feed for calves for conditioning the intestinal flora. | |
| MX2015007814A (en) | Strain of bifidobacterium animalis ssp. animalis. | |
| CN108514121A (en) | A kind of defaecation, the symphysis unit composition of toxin expelling and its preparation and application | |
| CN106727725A (en) | A kind of probiotics capsulae enterosolubilis and its utricule for treating enteric flora disturbance | |
| CN108670982A (en) | A kind of preparation method of probiotics chewing gum | |
| CN108541951A (en) | A kind of symphysis unit composition and its preparation for preventing senile dementia, enhancing memory | |
| CA3123125A1 (en) | Strains, composition and method of use | |
| Tewari et al. | A review on probiotic dairy products and digestive health | |
| CN105456563A (en) | Composition for improving intestinal functions | |
| Yu et al. | Milk fermented by combined starter cultures comprising three Lactobacillus strains exerts an alleviating effect on loperamide-induced constipation in BALB/c mice | |
| WO2020052869A1 (en) | Method for reducing the transfer of pathogenic microorganisms | |
| Delgado et al. | Glycerol supplementation enhances the protective effect of dietary FloraMax-B11 against Salmonella Enteritidis colonization in neonate broiler chickens | |
| Zerehpoosh et al. | Probiotics and health | |
| CN108310122A (en) | A kind of symphysis unit composition preventing oral peculiar smell and its preparation and application | |
| Verrucci et al. | Use of probiotics in medical devices applied to some common pathologies. | |
| CN108541950A (en) | A kind for the treatment of and symphysis unit composition and its preparation and the application of pre- anti-caries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180928 |